Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of spectinomycin hydrochloride injection for pelvic inflammatory disease
ChiCTR2000034896Phase 4Not yet recruiting
- Sponsor
- Fujian Maternal and Child Health Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of spectinomycin in Pelviabdominal infection, sponsored by Fujian Maternal and Child Health Hospital. Primary endpoint: McCormack scale score. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
spectinomycin
03
Conditions
Pelviabdominal infection
Beyond the preview
Go deeper on ChiCTR2000034896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034896.